Anti-epithelial membrane antigen monoclonal antibodies and radioimmunolocalization of colorectal cancer
โ Scribed by Mr C. Y. Yiu; L. A. Baker; P. B. Boulos
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- English
- Weight
- 500 KB
- Volume
- 78
- Category
- Article
- ISSN
- 0007-1323
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
The monoclonal antibodies LICR-LON M8 and 77-1, which react with epithelial membrane antigen, showed a strong reaction with colorectal cancer on immunohistochemistry. In a radioimmunolocalization study in patients with colorectal cancer, 111In-labelled M8 detected 13 of 16 tumour sites present in 16 patients. 111In-labelled 77-1 detected 10 of 15 tumour sites present in 14 patients. The high radioactive background in the liver prevented the detection of hepatic metastases in eight patients (five in the M8 and three in the 77-1 group). The mean(s.d.) tumour to normal colon ratio was 2ยท5(1ยท2) for M8 and 1ยท6(0ยท5) for 77-1 at day 6 after antibody administration. The mean(s.d.) tumour to blood ratio was 4ยท9(3ยท7) for M8 and 3ยท6(1ยท5) for 77-1. There was no statistical difference between these results. All scan-positive cancers reacted with M8 and 77-1 on immunohistochemistry. The results suggest that these monoclonal antibodies may have a role in the immunolocalization of colorectal cancer.
๐ SIMILAR VOLUMES
## Background. A new anti-carcinoembryonic antigen (CEA) antibody, BW 431/26 (Scintimun, Behring-Werke, Marburg, Germany), labeled with technetium pertechnetate (Tc-99m1, is an intact immunoglobulin GI monoclonal antibody that has been used to image colorectal cancer (CRC). This report is part of
Murine hybridoma were raised against the human colon carcinoma cell line CL-187. One clone was found to secrete a monoclonal antibody (ND-1) that recognizes a large external antigen (LEA) on human colon carcinoma cells. With indirect immunofluorescence on formaldehyde-fixed cells, more than 90% of t
Surgery, the most effective treatment for colon and rectal cancer, is based on empirical knowledge of the patterns of tumor spread, gross findings at laparotomy, and histologic confirmation of tumor-free margins. In spite of the many technical improvements in surgery, there has not been a significan